Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Despite a challenging 2025 where GenAI panic and style drift drove an 18% relative underperformance, the portfolio's operational fundamentals remain strong, prompting insider buying at an attractive 19x forward earnings multiple.
Full Quick Take
Despite a challenging 2025 where GenAI panic and style drift drove an 18% relative underperformance, the portfolio's operational fundamentals remain strong, prompting insider buying at an attractive 19x forward earnings multiple.
Underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trademark low-turnover, balance-sheet-focused approach.
Full Quick Take
Underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trademark low-turnover, balance-sheet-focused approach.
Maintaining a strong 14% CAGR since inception. Moving into 2025, the strategy focuses heavily on further portfolio concentration and minimizing fee drag.
Full Quick Take
Maintaining a strong 14% CAGR since inception. Moving into 2025, the strategy focuses heavily on further portfolio concentration and minimizing fee drag.